+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Eluting Sutures Market by Application (Cardiovascular, General Surgery, Gynecology), End User (Ambulatory Surgical Centers, Clinics, Hospitals), Drug Type, Material, Distribution Channel - Global Forecast 2025-2030- Product Image
Drug Eluting Sutures Market by Application (Cardiovascular, General Surgery, Gynecology), End User (Ambulatory Surgical Centers, Clinics, Hospitals), Drug Type, Material, Distribution Channel - Global Forecast 2025-2030- Product Image
New

Drug Eluting Sutures Market by Application (Cardiovascular, General Surgery, Gynecology), End User (Ambulatory Surgical Centers, Clinics, Hospitals), Drug Type, Material, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6122063
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Drug eluting sutures represent a paradigm shift in surgical practice by combining mechanical closure with targeted therapeutic delivery. These advanced medical devices integrate bioactive agents within the suture matrix, enabling controlled release of compounds such as anti-inflammatory, antimicrobial or growth factor molecules directly at the wound site. This dual functionality enhances wound healing, reduces infection risks and minimizes postoperative complications.

The evolution of drug eluting sutures can be traced through decades of material science breakthroughs and translational research. Early iterations focused on surface coatings that gradually dissolved, while next-generation designs incorporate microspheres or nanofibers embedded in synthetic or natural polymers to achieve sustained and localized drug diffusion. Moreover, the synergy between polymer engineering and pharmacology has fostered customizable release profiles, accommodating a broad spectrum of surgical applications. As healthcare providers strive to deliver better patient outcomes, drug eluting sutures have emerged as a critical innovation that bridges the gap between traditional hemostasis and targeted therapeutic intervention.

Examining the Paradigm Shifts That Are Redefining Drug Eluting Suture Development and Clinical Implementation Across Surgical Practices

Over the past several years, drug eluting sutures have experienced transformative shifts driven by cutting-edge manufacturing techniques, evolving regulatory landscapes and heightened clinician demand for multifunctional devices. Rapid advances in additive manufacturing and electrospinning have enabled the fabrication of sutures with precise control over fiber diameter, drug loading and matrix degradation kinetics. Consequently, developers now tailor drug concentration gradients along the suture to match tissue healing phases, ensuring therapeutic efficacy without systemic toxicity.

Concurrently, regulatory agencies worldwide have refined pathways for combination products, emphasizing rigorous biocompatibility testing, sterility assurance and pharmacokinetic profiling. This clarity has accelerated clinical adoption as surgeons gain confidence in predictable safety profiles. In parallel, multidisciplinary collaborations between polymer chemists, pharmacologists and biomedical engineers have produced biodegradable sutures with integrated antimicrobial coatings that remain effective over prolonged implantation periods. These converging dynamics underscore a rapidly maturing technology that is redefining the standard of care in cardiovascular, general, gynecological, ophthalmic and orthopedic procedures.

Analyzing the Far Reaching Effects of the 2025 United States Tariff Adjustments on the Accessibility and Affordability of Drug Eluting Sutures

The introduction of revised United States tariffs in 2025 has exerted a multifaceted impact on the drug eluting suture supply chain, influencing cost structures, procurement strategies and manufacturing footprints. Heightened duties on imported polymers, coatings and active pharmaceutical ingredients have elevated raw material expenses, prompting many producers to renegotiate supplier agreements or source alternative regional vendors to preserve margin stability. Consequently, some manufacturers have localized production to minimize tariff exposure, investing in domestic extrusion facilities and coating lines that reduce reliance on foreign imports.

Despite these adjustments, distributors and healthcare providers have remained resilient by optimizing inventory management and consolidating orders to achieve volume discounts. In addition, strategic partnerships between suture developers and contract manufacturers have emerged to share the burden of tariff-induced cost increases, enabling both parties to sustain competitive pricing. Looking beyond immediate cost implications, these supply chain realignments are fostering greater vertical integration and supply chain transparency, ultimately strengthening resilience against future trade fluctuations and geopolitical uncertainties.

Uncovering Segmentation Patterns That Illuminate Application, End User Distribution, Drug Typing, Material Composition and Channel Dynamics

A comprehensive examination of market segmentation reveals nuanced adoption patterns across application domains, end user environments, drug categories, material types and distribution pathways. In the surgical realm, cardiovascular procedures span both bypass surgery and valve repair, while general surgery encompasses abdominal, plastic and urological interventions. Gynecological, ophthalmic and orthopedic surgeries further illustrate the technology’s versatility, extending from joint reconstruction to sports medicine as clinical teams pursue sutures capable of delivering precise therapeutic payloads.

From the perspective of end users, ambulatory surgical centers-whether freestanding entities or hospital-affiliated units-alongside clinics and hospitals operating at secondary and tertiary care levels, demonstrate distinct procurement behaviors informed by procedure volumes, reimbursement frameworks and clinical protocols. In terms of drug type, anti-adhesion, anti-inflammatory formulations such as NSAID or steroid coated sutures, antimicrobial options including silver or triclosan coated fibers, and growth factor eluting designs featuring BMP or VEGF coatings, each address specific postoperative requirements. Material composition varies between natural substrates like catgut and silk and synthetic polymers such as poliglecaprone, polydioxanone and polyglactin, affecting degradation profiles and tissue reactivity. Finally, distribution evolves through inpatient and outpatient hospital pharmacies, direct manufacturer or third-party online channels, and chain or independent retail pharmacies, all of which shape accessibility and delivery timelines for clinicians and patients alike.

Mapping Regional Variances in Adoption, Regulatory Framing, Reimbursement Dynamics and Emerging Demand Across Global Geographies

Regional dynamics in drug eluting sutures manifest through distinctive regulatory frameworks, healthcare infrastructures and adoption curves across the Americas, EMEA and Asia-Pacific geographies. The Americas leverage advanced reimbursement models and integrated hospital networks to drive early clinical uptake, while regulatory agencies emphasize thorough device-drug interaction studies. In contrast, Europe, the Middle East and Africa present a tapestry of regulatory stringency, with centralized and decentralized approval pathways alongside varied economic environments influencing regional roll-out speeds.

Meanwhile, Asia-Pacific nations are at the forefront of local manufacturing investment, spurred by government incentives and growing surgical volumes. Emerging markets within this region pursue capacity building through public-private partnerships, aligning local clinical training with suture developers. Moreover, cross-border collaborations facilitate technology transfer and standardized quality assurance, accelerating adoption. As healthcare systems worldwide prioritize cost containment and outcome optimization, each region’s unique combination of policy drivers, reimbursement schemes and local innovation ecosystems will continue to shape the trajectory of drug eluting suture integration.

Identifying Key Industry Players Shaping the Competitive Landscape Through Strategic Partnerships Innovation Portfolios and Market Presence

Leading companies in the drug eluting suture arena are differentiating through diversified innovation pipelines, strategic alliances and targeted market expansions. Major medical device conglomerates have acquired specialized startups to bolster proprietary coating technologies and integrate advanced polymer chemistries. In parallel, midsize developers focus on niche applications such as ophthalmic or gynecological sutures, leveraging clinical trial collaborations to validate enhanced healing outcomes and secure key opinion leader endorsements.

Partnerships between material science innovators and pharmaceutical firms have resulted in patented drug encapsulation techniques that extend release windows while maintaining tensile strength. At the same time, contract manufacturing organizations have scaled capabilities to meet rising demand, forging supply agreements that guarantee quality standards and production scalability. Across this competitive landscape, companies prioritize value-based pricing models, robust post-market surveillance programs and experiential marketing strategies that highlight patient outcome improvements. This multi-dimensional approach is driving differentiation and reinforcing market positioning as innovation intensity accelerates.

Charting Strategic Recommendations for Industry Leaders to Leverage Technological Advances Enhance Supply Chains and Strengthen Market Positioning

Industry leaders should prioritize sustained investment in research and development to refine drug loading mechanisms and material biocompatibility, thus ensuring next-generation sutures meet evolving clinical demands. Building resilient supply chains through dual sourcing of polymers and active agents will mitigate risks associated with tariffs and geopolitical shifts. Furthermore, cultivating collaborative relationships with regulatory bodies early in the product development cycle can expedite approval timelines and clarify combination product pathways.

Organizations are encouraged to expand clinical engagement initiatives by supporting surgeon-led studies that demonstrate real-world efficacy and cost benefits, thereby strengthening reimbursement dossiers. Diversifying distribution networks to include both traditional pharmacy partners and emerging digital health platforms will enhance market reach and address evolving procurement preferences. Finally, embedding advanced analytics into post-market surveillance programs can yield actionable insights into device performance, feeding continuous improvement cycles and guiding strategic portfolio decisions.

Detailing Rigorous Research Methodology Combining Primary Stakeholder Interviews and Secondary Data Validation to Ensure Analytical Robustness

This analysis rests upon a robust methodology that integrates primary qualitative and rigorous secondary data sources. In-depth interviews with key opinion leaders-including cardiovascular and orthopedic surgeons, procurement executives and materials scientists-provided firsthand perspectives on clinical requirements, adoption barriers and performance expectations. These insights were augmented by examiner visits to manufacturing facilities and consultations with supply chain managers to validate production workflows and tariff mitigation strategies.

Complementing primary research, secondary sources such as peer-reviewed journals, regulatory filings, patent databases and white papers were systematically reviewed to establish historical trends in drug eluting suture development. Data triangulation techniques reconciled disparate findings across sources, ensuring the conclusions drawn are both reliable and reflective of current market realities. This structured approach to gathering and analyzing evidence underpins the comprehensive nature of the strategic insights presented.

Synthesizing Insights to Conclude on the Current State of Drug Eluting Sutures and Prospective Directions for Market Evolution

Overall, drug eluting sutures have emerged as a critical advancement that enhances postoperative care by delivering localized therapy while maintaining essential wound closure functions. Technological progress in polymer design, drug encapsulation and manufacturing processes has elevated safety profiles and expanded clinical applicability across diverse surgical specialties. Shifts in trade policy have catalyzed supply chain realignments that improve resilience, while regional dynamics underscore the importance of tailored market entry strategies.

As the competitive environment intensifies, companies that align innovation pipelines with clinician needs, navigate regulatory complexities proactively and leverage data-driven supply chain solutions will secure leadership positions. The synergistic integration of material science and pharmacology promises further breakthroughs, positioning drug eluting sutures at the forefront of next-generation wound management solutions. Stakeholders who act decisively today will shape the future of surgical care and achieve lasting impact on patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cardiovascular
      • Bypass Surgery
      • Valve Repair
    • General Surgery
      • Abdominal Surgery
      • Plastic Surgery
      • Urological Surgery
    • Gynecology
    • Ophthalmic
    • Orthopedic
      • Joint Reconstruction
      • Sports Medicine
  • End User
    • Ambulatory Surgical Centers
      • Freestanding Surgical Centers
      • Hospital Affiliated Centers
    • Clinics
    • Hospitals
      • Secondary Care
      • Tertiary Care
  • Drug Type
    • Anti-adhesion Eluting
    • Anti-inflammatory Eluting
      • Nsaid Coated
      • Steroid Coated
    • Antimicrobial Eluting
      • Silver Coated
      • Triclosan Coated
    • Growth Factor Eluting
      • Bmp Coated
      • Vegf Coated
  • Material
    • Natural
      • Catgut
      • Silk
    • Synthetic
      • Poliglecaprone
      • Polydioxanone
      • Polyglactin
  • Distribution Channel
    • Hospital Pharmacies
      • Inpatient Pharmacy
      • Outpatient Pharmacy
    • Online Pharmacies
      • Direct Manufacturer
      • Third-Party Vendors
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Ethicon, Inc.
  • Medtronic plc
  • B. Braun Melsungen AG
  • 3M Company
  • Teleflex Incorporated
  • Smith & Nephew plc
  • Surmodics, Inc.
  • Polyganics B.V.
  • Corza Medical, Inc.
  • Integra LifeSciences Holdings Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of biodegradable polymers with sustained antibiotic release profiles to prevent postoperative infections
5.2. Advancements in nanotechnology enabling targeted drug delivery through multifunctional surgical sutures
5.3. Rising adoption of antibacterial drug-eluting sutures in orthopedic procedures to reduce implant-associated infections
5.4. Collaborations between pharmaceutical and medical device companies to develop novel anti-inflammatory suture coatings
5.5. Regulatory approvals driving expansion of drug-eluting suture applications in cardiovascular surgery
5.6. Innovations in bioresorbable suture materials combining analgesic release for enhanced patient comfort
5.7. Cost-effectiveness analyses influencing hospital procurement of drug-eluting sutures over traditional alternatives
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Eluting Sutures Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.2.1. Bypass Surgery
8.2.2. Valve Repair
8.3. General Surgery
8.3.1. Abdominal Surgery
8.3.2. Plastic Surgery
8.3.3. Urological Surgery
8.4. Gynecology
8.5. Ophthalmic
8.6. Orthopedic
8.6.1. Joint Reconstruction
8.6.2. Sports Medicine
9. Drug Eluting Sutures Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Freestanding Surgical Centers
9.2.2. Hospital Affiliated Centers
9.3. Clinics
9.4. Hospitals
9.4.1. Secondary Care
9.4.2. Tertiary Care
10. Drug Eluting Sutures Market, by Drug Type
10.1. Introduction
10.2. Anti-adhesion Eluting
10.3. Anti-inflammatory Eluting
10.3.1. Nsaid Coated
10.3.2. Steroid Coated
10.4. Antimicrobial Eluting
10.4.1. Silver Coated
10.4.2. Triclosan Coated
10.5. Growth Factor Eluting
10.5.1. Bmp Coated
10.5.2. Vegf Coated
11. Drug Eluting Sutures Market, by Material
11.1. Introduction
11.2. Natural
11.2.1. Catgut
11.2.2. Silk
11.3. Synthetic
11.3.1. Poliglecaprone
11.3.2. Polydioxanone
11.3.3. Polyglactin
12. Drug Eluting Sutures Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.2.1. Inpatient Pharmacy
12.2.2. Outpatient Pharmacy
12.3. Online Pharmacies
12.3.1. Direct Manufacturer
12.3.2. Third-Party Vendors
12.4. Retail Pharmacies
12.4.1. Chain Pharmacies
12.4.2. Independent Pharmacies
13. Americas Drug Eluting Sutures Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Drug Eluting Sutures Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Drug Eluting Sutures Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Ethicon, Inc.
16.3.2. Medtronic plc
16.3.3. B. Braun Melsungen AG
16.3.4. 3M Company
16.3.5. Teleflex Incorporated
16.3.6. Smith & Nephew plc
16.3.7. Surmodics, Inc.
16.3.8. Polyganics B.V.
16.3.9. Corza Medical, Inc.
16.3.10. Integra LifeSciences Holdings Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DRUG ELUTING SUTURES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DRUG ELUTING SUTURES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DRUG ELUTING SUTURES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DRUG ELUTING SUTURES MARKET: RESEARCHAI
FIGURE 26. DRUG ELUTING SUTURES MARKET: RESEARCHSTATISTICS
FIGURE 27. DRUG ELUTING SUTURES MARKET: RESEARCHCONTACTS
FIGURE 28. DRUG ELUTING SUTURES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG ELUTING SUTURES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY VALVE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ABDOMINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ABDOMINAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY FREESTANDING SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY FREESTANDING SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-ADHESION ELUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-ADHESION ELUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY NSAID COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY NSAID COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY STEROID COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY STEROID COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SILVER COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SILVER COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY TRICLOSAN COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY TRICLOSAN COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY BMP COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY BMP COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY VEGF COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY VEGF COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CATGUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CATGUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SILK, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SILK, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY POLYGLACTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY POLYGLACTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DIRECT MANUFACTURER, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY DIRECT MANUFACTURER, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY THIRD-PARTY VENDORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY THIRD-PARTY VENDORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS DRUG ELUTING SUTURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES DRUG ELUTING SUTURES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 214. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 215. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 216. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 217. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 218. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 219. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 222. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 223. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 226. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 227. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2018-2024 (USD MILLION)
TABLE 228. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2025-2030 (USD MILLION)
TABLE 229. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2018-2024 (USD MILLION)
TABLE 230. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2025-2030 (USD MILLION)
TABLE 231. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2018-2024 (USD MILLION)
TABLE 232. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2025-2030 (USD MILLION)
TABLE 233. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 234. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 235. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 236. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 237. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 238. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 239. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 242. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 243. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 244. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 245. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 246. CANADA DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 250. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 251. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 252. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 253. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 254. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 255. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2018-2024 (USD MILLION)
TABLE 264. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2025-2030 (USD MILLION)
TABLE 265. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2018-2024 (USD MILLION)
TABLE 266. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2025-2030 (USD MILLION)
TABLE 267. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2018-2024 (USD MILLION)
TABLE 268. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2025-2030 (USD MILLION)
TABLE 269. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 270. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 271. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 272. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 273. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 274. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 275. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 278. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 279. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. MEXICO DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ANTI-INFLAMMATORY ELUTING, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ANTIMICROBIAL ELUTING, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY GROWTH FACTOR ELUTING, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY SYNTHETIC, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL DRUG ELUTING SUTURES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA DRUG ELUTING SUTURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA DR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Eluting Sutures market report include:
  • Ethicon, Inc.
  • Medtronic plc
  • B. Braun Melsungen AG
  • 3M Company
  • Teleflex Incorporated
  • Smith & Nephew plc
  • Surmodics, Inc.
  • Polyganics B.V.
  • Corza Medical, Inc.
  • Integra LifeSciences Holdings Corporation

Related Topics

Related Reports

Smart Sutures Market by Product Type (Absorbable, Nonabsorbable), Material Type (Polyester, Polyglycolic Acid, Polypropylene), Technology, Application, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Smart Sutures Market by Product Type (Absorbable, Nonabsorbable), Material Type (Polyester, Polyglycolic Acid, Polypropylene), Technology, Application, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Functional Suture Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Functional Suture Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Drug Eluting Stent Market by Type (Polymer Coated, Polymer Free), Drug (Biolimus Eluting, Everolimus Eluting, Paclitaxel Eluting), Application, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Drug Eluting Stent Market by Type (Polymer Coated, Polymer Free), Drug (Biolimus Eluting, Everolimus Eluting, Paclitaxel Eluting), Application, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Implantable Contraceptive Drug Eluting Devices Market by Product Type (Multi Rod, Single Rod), Drug Type (Etonogestrel, Levonorgestrel), End User, Distribution Channel, Polymer Material, Duration - Global Forecast 2025-2030 - Product Image

Implantable Contraceptive Drug Eluting Devices Market by Product Type (Multi Rod, Single Rod), Drug Type (Etonogestrel, Levonorgestrel), End User, Distribution Channel, Polymer Material, Duration - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.